Navigation Links
SIRO Clinpharm Showcases Biometrics Capabilities at the SCDM 2014 Annual Conference in Las Vegas

MUMBAI, India, October 2, 2014 /PRNewswire/ --

SIRO Clinpharm, an award-winning Clinical Research Organization (CRO) showcased its biometrics capabilities at the prestigious Annual Conference of the Society for Clinical Data Management (SCDM) 2014 in Las Vegas, where they were invited to speak at three sessions. SIRO experts presented on varied topics like 'data analytics to support fraud detection', 'clinical data management's role in late stage / registry studies' and 'benefits of working together as virtual and integrated teams'. The award-winning streak continued with SIRO winning the 'Outstanding Poster Presentation' award at this largest CDM exhibit.

As one of the pioneers of India's clinical data management industry, SIRO Clinpharm is uniquely positioned as the knowledge leader in this space. "With trials being conducted in different parts of the globe across several hundred sites, there are inherent advantages in managing all the biometrics activities from a single location. SIRO has developed integrated teams and leverages technology to expedite the biometrics activities without compromising quality, where various departments work like one virtual team. We call this philosophy, One Data, One Team", said Dr. Vatsal Shah, Vice President & Global Head, Biometrics, Medical Writing & Pharmacovigilance. The award-winning poster was a quintessential integrated team outcome with active involvement of the SIRO biostatistics, medical writing and graphics team.

"One Data, One Team reflects SIRO Clinpharm's commitment in addressing the clinical data quality challenges faced by our customers", said Mr. Satya Gottumukkala, President - Strategy & Corporate Development.

SIRO has been able to utilize its technology pool to crystallize this philosophy which offers sponsors a cost-efficient solution with a 'clinical edge' through experienced resources. "We demonstrate our motto of customer focus through our innovations. SIRO ReDM, our customized process for rescue studies, Paper+EDC, SIRO solution for hybrid studies, and SYNOPTIC, a report browser developed in-house, stem from customer needs and innovative thinking", reiterated Dr. Vatsal.

About SIRO Clinpharm
SIRO Clinpharm, winner of Frost & Sullivan 'Clinical Research Organization of the year' Healthcare Award is a drug development solutions provider to the global healthcare industry. Our subject expertise gives us an edge in clinical trial management, clinical data management, medical writing, biostatistics and statistical programming pharmacovigilance and clinical trial supplies management. We offer flexible business models across service verticals based on client needs.  Learn more:

Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
2. Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
3. Van Andel Institute Research Symposium Showcases Latest Developments In Parkinsons Research
4. Bayer CropScience Showcases Season-Long Solutions at Potato Expo
5. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
6. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
7. Rice Lake Weighing Systems Showcases Metrology Solutions for the 2014 NCSL International Workshop & Symposium
8. Ikonopedia Showcases New MQSA Management System and Reporting Modules at Intensive Breast Ultrasound Meeting
9. Cartes 2013: DERMALOG Presents World Firsts in Biometrics
10. Biometrics market in South East Asia and ANZ to grow at a CAGR of 15.82 percent over the period 2013-2018
11. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
Post Your Comments:
(Date:2/11/2020)... ... February 11, 2020 , ... ... from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous fixation ... Unlike extension block design, the Inspan device fixates the spine to allow ...
(Date:2/5/2020)... ... February 04, 2020 , ... Shoreline Biome , ... the strain level, has announced a new distribution partnership in Asia. , The ... products to companies and research organizations in China, Hong Kong, and Macau. , ...
(Date:2/3/2020)... ... February 03, 2020 , ... Global molecular diagnostics ... OmniType, the 11-locus, single tube multiplex successor to Holotype HLA is available through ... locus-multiplexing and short library preparation, for HLA genotyping from sample to answer in ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
Breaking Biology Technology:
(Date:1/29/2020)... ... January 29, 2020 , ... VGXI, a ... production of a DNA vaccine against the novel coronavirus (2019-nCoV) that has recently ... of up to $9 million from the Coalition for Epidemic Preparedness Innovations (CEPI) ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus Therapeutics ... noted investor, tech entrepreneur, and former senior management consultant at McKinsey & Company ... the global alternative investment firm. , “Chris Thorne has exceptional business acumen ...
(Date:1/23/2020)... ... January 23, 2020 , ... GIOSTAR/HEAMGEN ... from stem cells. The red blood cells are made utilizing a bioreactor ... for transfusion therapy and replaces the need for a human blood donor. ...
Breaking Biology News(10 mins):